Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study

To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Hea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of primary health care 2022-03, Vol.40 (1), p.39-47
Hauptverfasser: Mikkola, Ilona, Morgan, Simon, Winell, Klas, Jokelainen, Jari, Frittitta, Lucia, Heikkala, Eveliina, Hagnäs, Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 1
container_start_page 39
container_title Scandinavian journal of primary health care
container_volume 40
creator Mikkola, Ilona
Morgan, Simon
Winell, Klas
Jokelainen, Jari
Frittitta, Lucia
Heikkala, Eveliina
Hagnäs, Maria
description To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Health Centre. The municipal health centre, Rovaniemi, Finland. A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'. Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services. A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p 
doi_str_mv 10.1080/02813432.2022.2036458
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_02813432_2022_2036458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4ed2e2ff18b44beb81996c80f80404f5</doaj_id><sourcerecordid>2942013612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEosPAI4AssWHBFN-S2CwQVcWlUiU2sLYc53jqUcYOttNq3pZHwZlLoSzY-Pqd_5xj_1X1kuBzggV-h6kgjDN6TjGdB9bwWjyqFqTGdNW2lD-uFjOzmqGz6llKG4yJwJI9rc5YTbhoGrqofl2kFIzT2QWPgkUjxBS8HlyCHhkdAY2D9gnduXyDtsG7HKLza6R9uQ4-xzDMYWZw3hld1lM2YQvpLRojJBPdeFLeQl-I_W4OnrIrSf7kjW6r4-6QMkG8dQYSch6NBQGfjxXk3QiIot7pDjKk90UKhW7m90qlgAh6WN2FOPQo5anfPa-eWD0keHGcl9WPz5--X35dXX_7cnV5cb0ydUPzygiMRStr3hNphSG2M30jjdSYEQvatkIIbjsGLe5AdMCalrd9XQ5ozzhlbFldHXT7oDfq2I4K2qn9QYhrpWN2ZgDFoadArSWi47yDThApm1KAFZhjbuui9eGgNU5deTZT-o96eCD68Ma7G7UOt0piiZmUReDNUSCGnxOkrLYuGRjKV0KYkqINFVQKVuhl9fofdBOmWF6yUJJTTFhDaKHqA2ViSCmCvS-GYDX7UZ38qGY_qqMfS9yrvzu5jzoZsAAfD4DzNsSt3v-cyno3hGij9sYlxf6f4zfVL_ZE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2942013612</pqid></control><display><type>article</type><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><source>Taylor &amp; Francis Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</creator><creatorcontrib>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</creatorcontrib><description>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Health Centre. The municipal health centre, Rovaniemi, Finland. A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'. Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services. A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p &lt; 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p &lt; 0.001). Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D. Key Points Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with more frequent monitoring for clinical outcomes, more frequent prescription of cardiovascular and antihyperglycemic medication and more frequent utilisation of planned diabetes consultations when compared to usual care.</description><identifier>ISSN: 0281-3432</identifier><identifier>EISSN: 1502-7724</identifier><identifier>DOI: 10.1080/02813432.2022.2036458</identifier><identifier>PMID: 35148662</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Aged ; Blood pressure ; care plan ; Care plans ; Cholesterol ; Clinical outcomes ; Cross-Sectional Studies ; Customization ; Density ; Diabetes ; Diabetes Mellitus, Type 2 - therapy ; Drugs ; general practice services ; Glycated Hemoglobin A - analysis ; Goal achievement ; Health facilities ; Hemoglobin ; Humans ; Hypoglycemic Agents - therapeutic use ; Original ; Outpatients ; patient-centric care ; Patients ; Prescriptions ; Primary care ; Primary Health Care ; Retrospective Studies ; type 2 diabetes ; Type 2 diabetes mellitus</subject><ispartof>Scandinavian journal of primary health care, 2022-03, Vol.40 (1), p.39-47</ispartof><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</citedby><cites>FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090399/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090399/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2100,12844,27500,27922,27923,30997,53789,53791,59141,59142</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35148662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikkola, Ilona</creatorcontrib><creatorcontrib>Morgan, Simon</creatorcontrib><creatorcontrib>Winell, Klas</creatorcontrib><creatorcontrib>Jokelainen, Jari</creatorcontrib><creatorcontrib>Frittitta, Lucia</creatorcontrib><creatorcontrib>Heikkala, Eveliina</creatorcontrib><creatorcontrib>Hagnäs, Maria</creatorcontrib><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><title>Scandinavian journal of primary health care</title><addtitle>Scand J Prim Health Care</addtitle><description>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Health Centre. The municipal health centre, Rovaniemi, Finland. A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'. Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services. A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p &lt; 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p &lt; 0.001). Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D. Key Points Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with more frequent monitoring for clinical outcomes, more frequent prescription of cardiovascular and antihyperglycemic medication and more frequent utilisation of planned diabetes consultations when compared to usual care.</description><subject>Aged</subject><subject>Blood pressure</subject><subject>care plan</subject><subject>Care plans</subject><subject>Cholesterol</subject><subject>Clinical outcomes</subject><subject>Cross-Sectional Studies</subject><subject>Customization</subject><subject>Density</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Drugs</subject><subject>general practice services</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Goal achievement</subject><subject>Health facilities</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Original</subject><subject>Outpatients</subject><subject>patient-centric care</subject><subject>Patients</subject><subject>Prescriptions</subject><subject>Primary care</subject><subject>Primary Health Care</subject><subject>Retrospective Studies</subject><subject>type 2 diabetes</subject><subject>Type 2 diabetes mellitus</subject><issn>0281-3432</issn><issn>1502-7724</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEosPAI4AssWHBFN-S2CwQVcWlUiU2sLYc53jqUcYOttNq3pZHwZlLoSzY-Pqd_5xj_1X1kuBzggV-h6kgjDN6TjGdB9bwWjyqFqTGdNW2lD-uFjOzmqGz6llKG4yJwJI9rc5YTbhoGrqofl2kFIzT2QWPgkUjxBS8HlyCHhkdAY2D9gnduXyDtsG7HKLza6R9uQ4-xzDMYWZw3hld1lM2YQvpLRojJBPdeFLeQl-I_W4OnrIrSf7kjW6r4-6QMkG8dQYSch6NBQGfjxXk3QiIot7pDjKk90UKhW7m90qlgAh6WN2FOPQo5anfPa-eWD0keHGcl9WPz5--X35dXX_7cnV5cb0ydUPzygiMRStr3hNphSG2M30jjdSYEQvatkIIbjsGLe5AdMCalrd9XQ5ozzhlbFldHXT7oDfq2I4K2qn9QYhrpWN2ZgDFoadArSWi47yDThApm1KAFZhjbuui9eGgNU5deTZT-o96eCD68Ma7G7UOt0piiZmUReDNUSCGnxOkrLYuGRjKV0KYkqINFVQKVuhl9fofdBOmWF6yUJJTTFhDaKHqA2ViSCmCvS-GYDX7UZ38qGY_qqMfS9yrvzu5jzoZsAAfD4DzNsSt3v-cyno3hGij9sYlxf6f4zfVL_ZE</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Mikkola, Ilona</creator><creator>Morgan, Simon</creator><creator>Winell, Klas</creator><creator>Jokelainen, Jari</creator><creator>Frittitta, Lucia</creator><creator>Heikkala, Eveliina</creator><creator>Hagnäs, Maria</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis LLC</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QJ</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202203</creationdate><title>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</title><author>Mikkola, Ilona ; Morgan, Simon ; Winell, Klas ; Jokelainen, Jari ; Frittitta, Lucia ; Heikkala, Eveliina ; Hagnäs, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-c80087954d19f8c1fbcd69c9a031feaf78884fb3e70be8be36747d5b3e2d34233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Blood pressure</topic><topic>care plan</topic><topic>Care plans</topic><topic>Cholesterol</topic><topic>Clinical outcomes</topic><topic>Cross-Sectional Studies</topic><topic>Customization</topic><topic>Density</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Drugs</topic><topic>general practice services</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Goal achievement</topic><topic>Health facilities</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Original</topic><topic>Outpatients</topic><topic>patient-centric care</topic><topic>Patients</topic><topic>Prescriptions</topic><topic>Primary care</topic><topic>Primary Health Care</topic><topic>Retrospective Studies</topic><topic>type 2 diabetes</topic><topic>Type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikkola, Ilona</creatorcontrib><creatorcontrib>Morgan, Simon</creatorcontrib><creatorcontrib>Winell, Klas</creatorcontrib><creatorcontrib>Jokelainen, Jari</creatorcontrib><creatorcontrib>Frittitta, Lucia</creatorcontrib><creatorcontrib>Heikkala, Eveliina</creatorcontrib><creatorcontrib>Hagnäs, Maria</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scandinavian journal of primary health care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikkola, Ilona</au><au>Morgan, Simon</au><au>Winell, Klas</au><au>Jokelainen, Jari</au><au>Frittitta, Lucia</au><au>Heikkala, Eveliina</au><au>Hagnäs, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study</atitle><jtitle>Scandinavian journal of primary health care</jtitle><addtitle>Scand J Prim Health Care</addtitle><date>2022-03</date><risdate>2022</risdate><volume>40</volume><issue>1</issue><spage>39</spage><epage>47</epage><pages>39-47</pages><issn>0281-3432</issn><eissn>1502-7724</eissn><abstract>To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Health Centre. The municipal health centre, Rovaniemi, Finland. A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: 'no care plan entries' (usual care); '1-2 care plan entries'; and '3 or more care plan entries'. Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services. A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target (p &lt; 0.05). Patients without a care plan had more unplanned primary care physician contacts compared to patients in care plan groups (p &lt; 0.001). Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D. Key Points Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with more frequent monitoring for clinical outcomes, more frequent prescription of cardiovascular and antihyperglycemic medication and more frequent utilisation of planned diabetes consultations when compared to usual care.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>35148662</pmid><doi>10.1080/02813432.2022.2036458</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0281-3432
ispartof Scandinavian journal of primary health care, 2022-03, Vol.40 (1), p.39-47
issn 0281-3432
1502-7724
language eng
recordid cdi_crossref_primary_10_1080_02813432_2022_2036458
source Taylor & Francis Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Applied Social Sciences Index & Abstracts (ASSIA); EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aged
Blood pressure
care plan
Care plans
Cholesterol
Clinical outcomes
Cross-Sectional Studies
Customization
Density
Diabetes
Diabetes Mellitus, Type 2 - therapy
Drugs
general practice services
Glycated Hemoglobin A - analysis
Goal achievement
Health facilities
Hemoglobin
Humans
Hypoglycemic Agents - therapeutic use
Original
Outpatients
patient-centric care
Patients
Prescriptions
Primary care
Primary Health Care
Retrospective Studies
type 2 diabetes
Type 2 diabetes mellitus
title Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20personalised%20care%20plans%20with%20monitoring%20and%20control%20of%20clinical%20outcomes,%20prescription%20of%20medication%20and%20utilisation%20of%20primary%20care%20services%20in%20patients%20with%20type%202%20diabetes:%20an%20observational%20real-world%20study&rft.jtitle=Scandinavian%20journal%20of%20primary%20health%20care&rft.au=Mikkola,%20Ilona&rft.date=2022-03&rft.volume=40&rft.issue=1&rft.spage=39&rft.epage=47&rft.pages=39-47&rft.issn=0281-3432&rft.eissn=1502-7724&rft_id=info:doi/10.1080/02813432.2022.2036458&rft_dat=%3Cproquest_cross%3E2942013612%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2942013612&rft_id=info:pmid/35148662&rft_doaj_id=oai_doaj_org_article_4ed2e2ff18b44beb81996c80f80404f5&rfr_iscdi=true